These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8806804)

  • 1. Thrombin modulation of natural killer activity in human peripheral lymphocytes.
    Naldini A; Carney DH
    Cell Immunol; 1996 Aug; 172(1):35-42. PubMed ID: 8806804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells.
    Gunji Y; Lewis J; Gorelik E
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):663-72. PubMed ID: 2133246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J; Gulati SC
    Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biology of human natural killer cells.
    Whiteside TL; Herberman RB
    Ann Ist Super Sanita; 1990; 26(3-4):335-48. PubMed ID: 2091502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
    Kaufmann Y; Levanon M; Davidsohn J; Ramot B
    J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin.
    Shau H; Kim A; Golub SH
    J Leukoc Biol; 1992 Apr; 51(4):343-9. PubMed ID: 1564398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
    Hogan PG; Hapel AJ; Doe WF
    J Immunol; 1985 Sep; 135(3):1731-8. PubMed ID: 3926882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of organophosphorus pesticide-induced inhibition of cytolytic activity of killer cells.
    Li Q; Kawada T
    Cell Mol Immunol; 2006 Jun; 3(3):171-8. PubMed ID: 16893497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils.
    Shau HY; Golub SH
    J Immunol; 1989 Aug; 143(3):1066-72. PubMed ID: 2787346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clones derived from human natural killer cells are susceptible to lysis by human interleukin-2-activated killer cells.
    Fujiwara T; Loudon WG; Grimm EA
    Lymphokine Cytokine Res; 1993 Feb; 12(1):45-8. PubMed ID: 8096153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of natural killer function by nonlymphoid cells.
    Shau H; Roth MD; Golub SH
    Nat Immun; 1993; 12(4-5):235-49. PubMed ID: 8257829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
    Pope BL; Chourmouzis E; Victorino L; MacIntyre JP; Capetola RJ; Lau CY
    J Immunol; 1993 Sep; 151(6):3007-17. PubMed ID: 8376766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity.
    Medvedev AE; Johnsen AC; Haux J; Steinkjer B; Egeberg K; Lynch DH; Sundan A; Espevik T
    Cytokine; 1997 Jun; 9(6):394-404. PubMed ID: 9199873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of human T-lymphotropic virus type-1 (HTLV-1)-infected cell line MT-2, which is not killed by a natural killer cell line NK-92 but is killed by lymphokine-activated killer cells.
    Komatsu F; Yoshida S
    Oncol Res; 1999; 11(5):213-8. PubMed ID: 10608615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.